News
The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or ...
The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
GSK Plc’s blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe ...
1h
Stocktwits on MSNGSK’s Blenrep Underwhelms FDA Panel Over Dose Risk-Benefit Balance In Myeloma; Retail Traders Stay OptimisticRetail chatter around GSK picked up on Thursday after Blenrep, one of its cancer drugs, hit a roadblock with U.S. regulators.
Explore more
GSK (GSK) stock in focus as the U.S. FDA approves a new prefilled syringe presentation of its shingles vaccine, Shingrix.
GSK Plc (NYSE:GSK) stock fell 5% after a U.S. Food and Drug Administration advisory panel voted against recommending approval for its blood cancer drug Blenrep, citing concerns that risks outweigh ...
The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...
The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...
Mistral’s Le Chat adds deep research agent and voice mode to challenge OpenAI’s enterprise dominance
Mistral added deep research capabilities to its Le Chat platform, bringing it in direct competition against ChatGPT and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results